Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research is to learn if severe hypertension can be better
controlled by initially treating with a combination of drugs (Irbesartan/HCTZ), in patients
who are unlikely to achieve blood pressure (B/P) control with only one drug. In addition, the
study will also evaluate the safety and tolerability of the drugs.